| Stage | AVAH | % of rev | BOBS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $670M | 100.00% | $620M | 100.00% | AVAH ×1.08 |
| Gross profit | $219M | 32.59% | $319M | 51.50% | BOBS +18.9pp |
| Operating income | $80M | 11.93% | $78M | 12.67% | BOBS +0.7pp |
| Pre-tax income | $56M | 8.42% | $80M | 12.84% | BOBS +4.4pp |
| Net income | $40M | 6.01% | $58M | 9.33% | BOBS +3.3pp |
| Stage | AVAH | BOBS | Gap · A − B |
|---|---|---|---|
| Revenue | $670M100.00% | $620M100.00% | AVAH ×1.08 |
| Gross profit | 32.59%$219M | 51.50%$319M | BOBS +18.9pp |
| Operating income | 11.93%$80M | 12.67%$78M | BOBS +0.7pp |
| Pre-tax income | 8.42%$56M | 12.84%$80M | BOBS +4.4pp |
| Net income |
| 6.01%$40M |
| 9.33%$58M |
| BOBS +3.3pp |
None
No disclosed counterparties: AVAH.